Molecular Approaches to Diagnosis in Ewing Sarcoma: Fluorescence In Situ Hybridization (FISH)
- PMID: 33326094
- DOI: 10.1007/978-1-0716-1020-6_6
Molecular Approaches to Diagnosis in Ewing Sarcoma: Fluorescence In Situ Hybridization (FISH)
Abstract
The differential diagnosis of small round cell tumors (SRCT) crucially relies on the synoptic evaluation of morphology, immunohistochemical patterns, and molecular features. Though the implementation of broad RNA sequencing in diagnostic molecular pathology routines has substantially changed the standards of molecular affirmation of diagnoses, fluorescence in situ hybridization (FISH) on formalin-fixed, paraffin-embedded (FFPE) tissue sections is still an elementary tool to provide a rapid molecular corroboration of diagnoses, essentially required for therapeutic decisions. We discuss here the major FISH approaches currently employed in diagnostic molecular pathology, addressing classic Ewing sarcoma and differential diagnoses among SRCT which cannot sufficiently be ruled out by immunohistochemistry. This chapter will approach technical issues but particularly strategies and pitfalls in the interpretation of FISH patterns.
Keywords: BCOR; CIC; EWSR1; Ewing sarcoma; FISH; FUS; Small round cell tumor.
References
-
- Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing’s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67(7):1886–1893. https://doi.org/10.1002/1097-0142(19910401)67:7<1886::aid-cncr2820670... - DOI - PubMed
-
- Hornick JL (2014) Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors. Mod Pathol 27(Suppl 1):S47–S63. https://doi.org/10.1038/modpathol.2013.177 - DOI - PubMed
-
- Llombart-Bosch A, Machado I, Navarro S, Bertoni F, Bacchini P, Alberghini M, Karzeladze A, Savelov N, Petrov S, Alvarado-Cabrero I, Mihaila D, Terrier P, Lopez-Guerrero JA, Picci P (2009) Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch 455(5):397–411. https://doi.org/10.1007/s00428-009-0842-7 - DOI - PubMed
-
- Russell-Goldman E, Hornick JL, Qian X, Jo VY (2018) NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: diagnostic utility and pitfalls. Cancer Cytopathol 126(11):942–949. https://doi.org/10.1002/cncy.22056 - DOI - PubMed
-
- Shibuya R, Matsuyama A, Nakamoto M, Shiba E, Kasai T, Hisaoka M (2014) The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465(5):599–605. https://doi.org/10.1007/s00428-014-1627-1 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
